Slate Medicines | $130,000,000 | (Feb 25, 2026)
Letter AI | $40,000,000 | (Feb 25, 2026)
Subject | $28,000,000 | (Feb 25, 2026)
Certified by Founder
Lodge
Ammobia
start up
United States
- San Francisco, California
- 16/01/2026
- Seed
- $7,500,000
Ammobia is developing Haber Bosch 2.0 - a process for clean ammonia production. We leverage advances in materials science and catalysis to produce green ammonia at low cost. Our process and systems work across production scales, enabling ammonia as a clean chemical, fertilizer, and energy carrier for a decarbonized future
Ammobia was founded by Karen Baert and Tristan Gilbert, recognized by Forbes 30 under 30 and supported by Starlight Ventures, Collaborative Fund, Arosa Capital, Chevron Technology Ventures and more
- Industry Chemical Manufacturing
- Website https://www.ammobia.co/
- LinkedIn https://www.linkedin.com/company/ammobia-inc/
KrisAtWork | $3,000,000 | (Feb 25, 2026)
Centauri Therapeutics Limited | $8,107,170 | (Feb 25, 2026)
Slang AI | $36,000,000 | (Feb 25, 2026)
Brilliant Harvest Inc. | $4,000,000 | (Feb 25, 2026)
Koah | $20,500,000 | (Feb 25, 2026)
Nimble | $47,000,000 | (Feb 25, 2026)
General Magic | $7,200,000 | (Feb 25, 2026)
Circadian Risk Inc. | $6,000,000 | (Feb 25, 2026)
Neural Earth | $9,300,000 | (Feb 25, 2026)
Jampack AI | $3,200,000 | (Feb 25, 2026)